You are here

  • Home
  • Archive
  • Volume 10, Issue 3
  • Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer

Article metrics

Article menu
Oncolytic and local immunotherapy
Original research
Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer

 

Online download statistics by month:

Online download statistics by month: March 2022 to November 2024

AbstractFullPdf
Mar 2022583602169
Apr 2022166181116
May 202215515985
Jun 202212112440
Jul 202211612149
Aug 202216116647
Sep 202213714380
Oct 202213814260
Nov 20229910137
Dec 2022949439
Jan 2023757526
Feb 202310210257
Mar 2023565747
Apr 2023545538
May 2023404030
Jun 2023454534
Jul 2023383935
Aug 2023404015
Sep 2023313119
Oct 2023252516
Nov 2023575715
Dec 2023404126
Jan 2024363632
Feb 2024535432
Mar 20245456197
Apr 2024454726
May 2024464734
Jun 2024565736
Jul 2024818143
Aug 2024363619
Sep 2024393935
Oct 2024626231
Nov 2024535423
Total293430091588